What is it about?
Congenital Erythrocytosis (CE), or congenital polycythemia, represents a rare and heterogeneous clinical entity. It is caused by deregulated red blood cell production where erythrocyte overproduction results in elevated hemoglobin and hematocrit levels.
Featured Image
Why is it important?
Despite recent important discoveries in the molecular pathogenesis of CE, the molecular causes remain to be identified in about 70% of the patients. With the objective of collecting all the published and unpublished cases of CE the COST action MPN&MPNr-Euronet developed a comprehensive internet-based database focusing on the registration of clinical history, hematological, biochemical and molecular data (http://www.erythrocytosis.org/).
Perspectives
Read the Original
This page is a summary of: Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases, Human Mutation, October 2013, Wiley,
DOI: 10.1002/humu.22448.
You can read the full text:
Contributors
The following have contributed to this page